Here are six quick facts:
1. The shares were sold at an average price of $18.52, for a total of $1.32 million.
2. Post the transaction, Mr. Nanavaty directly owns 134,534 shares of the company’s stock, valued at approximately $2.49 million.
3. The company has a 52-week low of $11.10 and a 52-week high of $18.62.
4. The stock’s 50-day moving average is $17 and its 200-day moving average is $15.
5. The company’s market cap is $24.55 billion.
6. The stock has a consensus rating of “buy” and an average price target of $18.42.
More articles on GI/endoscopy:
FDA clears 2 GI/endoscopy devices in May
Gastro Health launches online support community for GI patients: 4 key notes
Dr. Peter Cotton leads national study of gallbladder surgery
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
